Center differences and cross-national invariance in help-seeking for panic disorder. A report from the cross-national collaborative panic study
- PMID: 1621138
- DOI: 10.1007/BF00788759
Center differences and cross-national invariance in help-seeking for panic disorder. A report from the cross-national collaborative panic study
Abstract
Help-seeking behaviour for treatment of panic disorder was investigated in the sample of the Cross-National Collaborative Panic Study Second Phase. A total of 1168 patients were entered into this trial in 14 countries. Although there were significant center differences in prior treatment and utilization of health services there were also similarities. Treatment had been provided mainly by general practitioners. Drug treatment consisted mostly of prescription of classical tranquilizers and had a longer duration than treatment by psychotherapy. Patients with agoraphobic avoidance, past major depression and longer duration of illness used medical and psychiatric treatment facilities more intensely. Older and more severely disabled subjects were more frequently treated by medical health care providers and were more likely to receive psychotropic drugs. The results indicate that general practitioners carry an important load in the treatment of panic disorders but may need more information about recent development in pharmacotherapy for this condition.
Similar articles
-
Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators.Br J Psychiatry. 1992 Feb;160:191-202; discussion 202-5. doi: 10.1192/bjp.160.2.191. Br J Psychiatry. 1992. PMID: 1540759 Clinical Trial.
-
Service utilization and expenditures for the treatment of panic disorder.Gen Hosp Psychiatry. 1997 Mar;19(2):82-8. doi: 10.1016/s0163-8343(96)00154-5. Gen Hosp Psychiatry. 1997. PMID: 9097062 Clinical Trial.
-
Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo.J Affect Disord. 1994 Apr;30(4):273-81. doi: 10.1016/0165-0327(94)90134-1. J Affect Disord. 1994. PMID: 8014326 Clinical Trial.
-
Drug treatment of panic disorder.Pharmacol Toxicol. 1993 Jun;72(6):344-53. doi: 10.1111/j.1600-0773.1993.tb01343.x. Pharmacol Toxicol. 1993. PMID: 8103214 Review.
-
Panic disorder: long-term pharmacotherapy and discontinuation.J Clin Psychopharmacol. 1998 Dec;18(6 Suppl 2):12S-18S. doi: 10.1097/00004714-199812001-00004. J Clin Psychopharmacol. 1998. PMID: 9872708 Review.
Cited by
-
Addressing the challenges of a cross-national investigation: lessons from the Pittsburgh-Pisa study of treatment-relevant phenotypes of unipolar depression.Clin Trials. 2008;5(3):253-61. doi: 10.1177/1740774508091965. Clin Trials. 2008. PMID: 18559415 Free PMC article.
-
New developments in panic disorder.Curr Psychiatry Rep. 2000 Aug;2(4):353-7. doi: 10.1007/s11920-000-0081-8. Curr Psychiatry Rep. 2000. PMID: 11122981 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous